Head and neck cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with oral-head and neck squamous cell carcinoma who were diagnosed and treated in the multi-center medical institutions of this project from 2014 to 2023; 2) Pathological diagnosis of squamous cell carcinoma; 3) The primary site of the tumor is the oral cavity, oropharynx and other head and neck parts; 4) Tumor staging was carried out according to the (AJCC) TNM staging system; 5) Receiving one or more methods of radical surgery, radiotherapy, or drug therapy.
Exclusion criteria
Exclusion criteria: 1) Patients with other malignant tumors at the same time; 2) Patients who have not received any treatment or the treatment mode is unclear; 3) Patients who are unable to obtain pathological diagnosis or clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival, OS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-Free Survival, PFS; | — |
Countries
China
Contacts
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine